Related content

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li   Hu Cheng-Ping   Yang Hua-ping   Li Yuan-yuan   Gu Qi-hua   Wu Lielin  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite

Clinical development of EGFR-tyrosine kinase inhibitors in Japan

By Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 33-37

Springer Publishing Company

Access to resources Recommend Favorite

Clinical development of EGFR-tyrosine kinase inhibitors in Japan

By Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 33-37

Springer Publishing Company

Access to resources Recommend Favorite

Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis

By Keren Shen   Shoude Zhang   Lu Zhao   Beibei Yang  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2285-2295

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: A systematic review and meta-analysis

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 959-967

Science Publishers

Access to resources Recommend Favorite